Lead Compound Refinement
Lead Compound Refinement is a methodological process within ligand efficiency optimization that systematically modifies the structural and physicochemical properties of a lead compound to enhance its binding affinity, selectivity, and drug-like characteristics while maintaining optimal ligand efficiency.
15
Publications
664
Citations
79
Authors
14
Institutions
Publications per year
2017–2026
3
15
John J. Parlow, Deborah A. Mischke, Scott S. Woodard · The Journal of Organic Chemistry · 1997 · 96 citations
Robert M. Adlington, Jack E. Baldwin, Gerald W. Becker et al. · Journal of Medicinal Chemistry · 2001 · 76 citations · Full text
1–5 of 15
79
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 79
14
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
2 h-index
5 publications
114 citations
Jaypee University of Information Technology
Solan, India
1 h-index
2 publications
28 citations
Roche (Switzerland)
Basel, Switzerland
1 h-index
2 publications
116 citations
University of Oxford
Oxford, United Kingdom
1 h-index
12 publications
912 citations

University of Padua
Padua, Italy
1 h-index
4 publications
180 citations
Takeda (United States)
Deerfield, United States
1 h-index
20 publications
860 citations

Newcastle University
Newcastle upon Tyne, United Kingdom
1 h-index
1 publications
54 citations
Institut Químic de Sarrià
Barcelona, Spain
1 h-index
2 publications
28 citations
1–8 of 14
2 publications · 68 citations
2
h-index
1 publications · 15 citations
1
h-index
1 publications · 25 citations
1
h-index
1 publications · 30 citations
1
h-index
1 publications · 76 citations
1
h-index
1–5